Podcast description: centenarians' protective genes and aging science with Dr. Nir Barzilai
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedThe description says Dr. Nir Barzilai studies protective genes that delay aging and age-related disease in people over 100, and that the episode discusses drugs, peptides, biological age tests and cell therapies; the video itself was not reviewed. [1]
Dr. Nir Barzilai researches protective genes that delay aging and age-related diseases in people over 100, according to the description. [1]
The description says his research shows healthy, long life cannot be explained by nutrition, exercise and supplements alone. [1]
The description says the episode discusses the future of biological age tests and the evidence levels of hyperbaric oxygen and stem cell treatments. [1]
Barzilai's centenarian gene research
The description introduces Dr. Nir Barzilai as professor of medicine and genetics at Albert Einstein College of Medicine and director of a geroscience institute. It says he researches protective genes that delay aging and age-related diseases in people over 100. His research is said to show that healthy, long life cannot be explained by nutrition, exercise and supplements alone. The description frames the episode around the question of how some people pass 100 despite not following healthy-living rules. [1]
Drugs, peptides and biological age tests
The description lists topics the episode covers: how the effects of growth hormone and IGF-1 change with age; the longevity potential of drugs such as metformin, GLP-1 and SGLT2 inhibitors; risks of the peptides MOTS-c and Humanin; and unnecessary supplement use. It also says the future of biological age tests, the evidence levels for hyperbaric oxygen and stem cell treatments, and why aging biology rather than disease treatment should be targeted are discussed. Barzilai is described as a pioneer behind the TAME study, which examines metformin's effect on aging. The description gives no results from these discussions. [1]
Stated goal: healthspan, not just lifespan
The description says the main goal is not only living longer but staying healthy until the end of life. It presents the episode as a conversation on the future of aging, preventive medicine and the science of longer, healthier living. A disclaimer states the information is for general information only and is not intended to guide diagnosis or treatment. The description does not report study designs, sample sizes or outcomes for the topics listed. [1]
Context & limits
This is based only on the video description; the video and transcript were not reviewed. The description names topics but reports no study designs, sample sizes, follow-up or results, and it is not medical advice.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
koruyucu genleri araştırıyor
yalnızca beslenme, egzersiz ve takviyelerle açıklanamayacağını
hiperbarik oksijen ve kök hücre tedavilerinin kanıt
About this video
Creator description · original textText language: Turkish
Ayık Kafa · 2 min · Source published: 2026-10-17
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.